Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 331

1.

Management of atrial fibrillation in patients with chronic kidney disease in clinical practice: a joint European Heart Rhythm Association (EHRA) and European Renal Association/European Dialysis and Transplantation Association (ERA/EDTA) physician-based survey.

Potpara TS, Ferro C, Lip GYH, Dan GA, Lenarczyk R, Mallamaci F, Ortiz A, Sarafidis P, Ekart R, Dagres N.

Europace. 2020 Jan 21. pii: euz358. doi: 10.1093/europace/euz358. [Epub ahead of print]

PMID:
31965154
2.

Hypertension management in chronic kidney disease.

Mallamaci F, Pisano A, Tripepi G.

Nephrol Dial Transplant. 2020 Jan 10. pii: gfz279. doi: 10.1093/ndt/gfz279. [Epub ahead of print] No abstract available.

PMID:
31923306
3.

Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study.

Torino C, Gargani L, Sicari R, Letachowicz K, Ekart R, Fliser D, Covic A, Siamopoulos K, Stavroulopoulos A, Massy ZA, Fiaccadori E, Regolisti G, Bachelet T, Slotki I, Martinez-Castelao A, Coudert-Krier MJ, Rossignol P, Hannedouche T, Wiecek A, Sarafidis P, Battaglia Y, Prohić N, Klinger M, Hojs R, Seiler-Mußler S, Lizzi F, Siriopol D, Balafa O, Shavit L, Loutradis C, Seidowsky A, Tripepi R, Mallamaci F, Tripepi G, Picano E, London GM, Zoccali C.

J Nephrol. 2020 Jan 8. doi: 10.1007/s40620-019-00696-x. [Epub ahead of print]

PMID:
31916229
4.

FGF23 and the PTH response to paricalcitol in chronic kidney disease.

D'Arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

Eur J Clin Invest. 2020 Feb;50(2):e13196. doi: 10.1111/eci.13196. Epub 2020 Jan 9.

PMID:
31863599
5.

Prognostic values of left ventricular mass index in chronic kidney disease patients.

Tripepi G, D'Arrigo G, Mallamaci F, London G, Tangri N, Hsu JY, Feldman H, Zoccali C.

Nephrol Dial Transplant. 2019 Dec 20. pii: gfz254. doi: 10.1093/ndt/gfz254. [Epub ahead of print]

PMID:
31860093
6.

Identification of the Uric Acid Thresholds Predicting an Increased Total and Cardiovascular Mortality Over 20 Years.

Virdis A, Masi S, Casiglia E, Tikhonoff V, Cicero AFG, Ungar A, Rivasi G, Salvetti M, Barbagallo CM, Bombelli M, Dell'Oro R, Bruno B, Lippa L, D'Elia L, Verdecchia P, Mallamaci F, Cirillo M, Rattazzi M, Cirillo P, Gesualdo L, Mazza A, Giannattasio C, Maloberti A, Volpe M, Tocci G, Georgiopoulos G, Iaccarino G, Nazzaro P, Parati G, Palatini P, Galletti F, Ferri C, Desideri G, Viazzi F, Pontremoli R, Muiesan ML, Grassi G, Borghi C; from the Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension.

Hypertension. 2020 Feb;75(2):302-308. doi: 10.1161/HYPERTENSIONAHA.119.13643. Epub 2019 Dec 9.

PMID:
31813345
7.

Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study.

Panuccio V, Tripepi R, Parlongo G, Mafrica A, Caridi G, Catalano F, Marino F, Tripepi G, Mallamaci F, Zoccali C.

J Nephrol. 2019 Nov 5. doi: 10.1007/s40620-019-00666-3. [Epub ahead of print]

PMID:
31686409
8.

Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study.

Casiglia E, Tikhonoff V, Virdis A, Masi S, Barbagallo CM, Bombelli M, Bruno B, Cicero AFG, Cirillo M, Cirillo P, Desideri G, D'Elia L, Ferri C, Galletti F, Gesualdo L, Giannattasio C, Iaccarino G, Lippa L, Mallamaci F, Maloberti A, Mazza A, Muiesan ML, Nazzaro P, Palatini P, Parati G, Pontremoli R, Quarti-Trevano F, Rattazzi M, Rivasi G, Salvetti M, Tocci G, Ungar A, Verdecchia P, Viazzi F, Volpe M, Grassi G, Borghi C; Working Group on Uric Acid and Cardiovascular Risk of the Italian Society of Hypertension (SIIA).

J Hypertens. 2020 Mar;38(3):412-419. doi: 10.1097/HJH.0000000000002287.

PMID:
31644519
9.

Paving the way towards gender equality: how are we faring in nephrology?

Stevens KI, Soler MJ, Bruchfeld A, Mallamaci F.

Nephrol Dial Transplant. 2019 Aug 9. pii: gfz165. doi: 10.1093/ndt/gfz165. [Epub ahead of print] No abstract available.

PMID:
31407783
10.

Erratum to: SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Aug 9. pii: gfz137. doi: 10.1093/ndt/gfz137. [Epub ahead of print] No abstract available.

PMID:
31397476
11.

Physical functioning and mortality in very old patients on dialysis.

Torino C, Raso FM, van Saase JLCM, Panuccio V, Tripepi R, Vilasi A, Postorino M, Tripepi G, Mallamaci F, Zoccali C.

Arch Gerontol Geriatr. 2019 Nov - Dec;85:103918. doi: 10.1016/j.archger.2019.103918. Epub 2019 Jul 27.

PMID:
31376743
12.

Lung Ultrasound-Guided Dry-Weight Reduction in Hemodialysis Patients Does Not Affect Short-Term Blood Pressure Variability.

Loutradis C, Sarafidis PA, Theodorakopoulou M, Ekart R, Alexandrou ME, Pyrgidis N, Angeloudi E, Tzanis G, Toumpourleka M, Papadopoulou D, Mallamaci F, Zoccali C, Papagianni A.

Am J Hypertens. 2019 Jul 17;32(8):786-795. doi: 10.1093/ajh/hpz064.

PMID:
31162530
13.

Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis.

Pisano A, Bolignano D, Mallamaci F, D'Arrigo G, Halimi JM, Persu A, Wuerzner G, Sarafidis P, Watschinger B, Burnier M, Zoccali C.

Nephrol Dial Transplant. 2019 May 29. pii: gfz092. doi: 10.1093/ndt/gfz092. [Epub ahead of print]

PMID:
31143926
14.

Effects of Sevelamer Carbonate in Patients With CKD and Proteinuria: The ANSWER Randomized Trial.

Ruggiero B, Trillini M, Tartaglione L, Rotondi S, Perticucci E, Tripepi R, Aparicio C, Lecchi V, Perna A, Peraro F, Villa D, Ferrari S, Cannata A, Mazzaferro S, Mallamaci F, Zoccali C, Bellasi A, Cozzolino M, Remuzzi G, Ruggenenti P, Kohan DE; ANSWER Study Organization.

Am J Kidney Dis. 2019 Sep;74(3):338-350. doi: 10.1053/j.ajkd.2019.01.029. Epub 2019 Apr 23.

PMID:
31027883
15.

Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study.

Spoto B, Kakkar R, Lo L, Devalaraja M, Pizzini P, Torino C, Leonardis D, Cutrupi S, Tripepi G, Mallamaci F, Zoccali C.

J Clin Med. 2019 Apr 16;8(4). pii: E523. doi: 10.3390/jcm8040523.

16.

Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis.

Grassi G, D'Arrigo G, Pisano A, Bolignano D, Mallamaci F, Dell'Oro R, Quarti-Trevano F, Seravalle G, Mancia G, Zoccali C.

J Hypertens. 2019 Sep;37(9):1746-1756. doi: 10.1097/HJH.0000000000002093.

PMID:
30950979
17.

Erratum.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 28. pii: gfz047. doi: 10.1093/ndt/gfz047. [Epub ahead of print] No abstract available.

PMID:
30820538
18.

SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.

Sarafidis P, Ferro CJ, Morales E, Ortiz A, Malyszko J, Hojs R, Khazim K, Ekart R, Valdivielso J, Fouque D, London GM, Massy Z, Ruggenenti P, Porrini E, Wiecek A, Zoccali C, Mallamaci F, Hornum M.

Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230. doi: 10.1093/ndt/gfy407.

PMID:
30753708
19.

Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease.

Panuccio V, Pizzini P, Parlongo G, Caridi G, Tripepi R, Mafrica A, Cutrupi S, D'Arrigo G, Porto G, Garofalo C, Provenzano M, Tripepi G, Mallamaci F, Plebani M, Zoccali C.

Clin Chem Lab Med. 2019 Jul 26;57(8):1162-1168. doi: 10.1515/cclm-2018-1227.

PMID:
30753154
20.

Nonproteinuric progressive diabetic kidney disease.

Zoccali C, Mallamaci F.

Curr Opin Nephrol Hypertens. 2019 May;28(3):227-232. doi: 10.1097/MNH.0000000000000489.

PMID:
30672815
21.

Erratum.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2019 Jan 21. doi: 10.1093/ndt/gfy408. [Epub ahead of print] No abstract available.

PMID:
30668741
22.

Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study.

Zoccali C, D'Arrigo G, Leonardis D, Pizzini P, Postorino M, Tripepi G, Mallamaci F.

J Hypertens. 2019 Jul;37(7):1359-1365. doi: 10.1097/HJH.0000000000002030.

PMID:
30633126
23.

Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients.

Mallamaci F, Tripepi G, D'Arrigo G, Borrelli S, Garofalo C, Stanzione G, Provenzano M, De Nicola L, Conte G, Minutolo R, Zoccali C.

Clin J Am Soc Nephrol. 2019 Feb 7;14(2):233-240. doi: 10.2215/CJN.04030318. Epub 2019 Jan 2.

24.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2019 Feb;15(2):121. doi: 10.1038/s41581-018-0099-y.

PMID:
30538326
25.

Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study.

Mallamaci F, Tripepi R, D'Arrigo G, Porto G, Versace MC, Marino C, Sanguedolce MC, Testa A, Tripepi G, Zoccali C.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1558-1564. doi: 10.1093/ndt/gfy355.

PMID:
30476170
26.

The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease.

Torino C, Panuccio V, Tripepi R, Vilasi A, Postorino M, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2020 Jan 1;35(1):170-175. doi: 10.1093/ndt/gfy334.

PMID:
30445469
27.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
28.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2019 Feb;15(2):121.

PMID:
30361677
29.

Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial.

Baggetta R, D'Arrigo G, Torino C, ElHafeez SA, Manfredini F, Mallamaci F, Zoccali C, Tripepi G; EXCITE Working group.

BMC Geriatr. 2018 Oct 20;18(1):248. doi: 10.1186/s12877-018-0938-5.

30.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.

Torino C, Pizzini P, Cutrupi S, Postorino M, Tripepi G, Mallamaci F, Reiser J, Zoccali C; PROGREDIRE Working Group.

Kidney Int Rep. 2018 May 22;3(5):1100-1109. doi: 10.1016/j.ekir.2018.05.004. eCollection 2018 Sep.

31.

A New Treatment for Calciphylaxis in Hemodialysis Patients?

Zoccali C, Mallamaci F.

Am J Nephrol. 2018;48(3):165-167. doi: 10.1159/000491882. Epub 2018 Sep 3. No abstract available.

32.

Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.

Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy263. No abstract available.

PMID:
30113666
33.

Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Managing Volume Overload.

Zoccali C, Mallamaci F.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1432-1434. doi: 10.2215/CJN.01360118. Epub 2018 Aug 15. No abstract available.

34.

Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.

Provenzano M, Chiodini P, Minutolo R, Zoccali C, Bellizzi V, Conte G, Locatelli F, Tripepi G, Del Vecchio L, Mallamaci F, Di Micco L, Russo D, Heerspink HJL, De Nicola L.

Nephrol Dial Transplant. 2020 Jan 1;35(1):138-147. doi: 10.1093/ndt/gfy217.

PMID:
30053127
35.

Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.

Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.

Nephrol Dial Transplant. 2019 Sep 1;34(9):1542-1548. doi: 10.1093/ndt/gfy147. Erratum in: Nephrol Dial Transplant. 2018 Oct 1;33(10):1872.

PMID:
30007295
36.

Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease.

Borrelli S, Garofalo C, Mallamaci F, Tripepi G, Stanzione G, Provenzano M, Conte G, De Nicola L, Zoccali C, Minutolo R.

J Hypertens. 2018 Dec;36(12):2398-2405. doi: 10.1097/HJH.0000000000001825.

PMID:
29995698
37.

Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses.

Grassi G, Pisano A, Bolignano D, Seravalle G, D'Arrigo G, Quarti-Trevano F, Mallamaci F, Zoccali C, Mancia G.

Hypertension. 2018 Aug;72(2):483-491. doi: 10.1161/HYPERTENSIONAHA.118.11038. Epub 2018 Jun 18.

PMID:
29915014
38.

Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease.

Tripepi G, Agharazii M, Pannier B, D'Arrigo G, Mallamaci F, Zoccali C, London G.

Hypertension. 2018 Jun;71(6):1126-1132. doi: 10.1161/HYPERTENSIONAHA.118.10930. Epub 2018 Apr 30.

PMID:
29712739
39.

The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study.

Spoto B, Ntounousi E, Testa A, Liakopoulos V, D'Arrigo G, Tripepi G, Parlongo RM, Sanguedolce MC, Mallamaci F, Zoccali C.

J Hypertens. 2018 Aug;36(8):1705-1711. doi: 10.1097/HJH.0000000000001746.

PMID:
29702498
40.

Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients.

Zoccali C, Mallamaci F.

Am J Nephrol. 2018;47(4):251-253. doi: 10.1159/000488287. Epub 2018 Apr 25. No abstract available.

41.

Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.

D'arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2019 May 1;34(5):819-824. doi: 10.1093/ndt/gfy085.

PMID:
29668990
42.

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term.

Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Muiesan ML, Mannelli M, Negro A, Palumbo G, Parenti G, Rossi E, Mantero F; PAPY Study Investigators.

Hypertension. 2018 Apr;71(4):585-591. doi: 10.1161/HYPERTENSIONAHA.117.10596. Epub 2018 Feb 26.

PMID:
29483224
43.

Moderator's view: Low-protein diet in chronic kidney disease: effectiveness, efficacy and precision nutritional treatments in nephrology.

Zoccali C, Mallamaci F.

Nephrol Dial Transplant. 2018 Mar 1;33(3):387-391. doi: 10.1093/ndt/gfx374.

PMID:
29471510
44.

Neuropeptide Y and chronic kidney disease progression: a cohort study.

Zoccali C, D'Arrigo G, Leonardis D, Pizzini P, Postorino M, Tripepi G, Mallamaci F, van den Brand J, van Zuilen A, Wetzels J, Bots ML, Blankestijn P.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1805-1812. doi: 10.1093/ndt/gfx351.

PMID:
29370406
45.

Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.

Torino C, Pizzini P, Cutrupi S, Tripepi R, Vilasi A, Tripepi G, Mallamaci F, Zoccali C.

Oxid Med Cell Longev. 2017;2017:2801324. doi: 10.1155/2017/2801324. Epub 2017 Dec 6.

46.

Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.

Spoto B, Pizzini P, Cutrupi S, Tripepi G, Curatola G, Mallamaci F, Zoccali C.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):291-297. doi: 10.1016/j.numecd.2017.11.010. Epub 2017 Dec 7.

PMID:
29307660
47.

Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial.

Spoto B, Pizzini P, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1764-1769. doi: 10.1093/ndt/gfx344.

PMID:
29304245
48.

Uric acid in chronic kidney disease: the quest for causality continues.

Zoccali C, Mallamaci F.

Nephrol Dial Transplant. 2018 Feb 1;33(2):193-195. doi: 10.1093/ndt/gfx341. No abstract available.

PMID:
29294051
49.

The overdriven glomerulus as a cardiovascular risk factor.

Zoccali C, Mallamaci F.

Kidney Int. 2018 Jan;93(1):13-15. doi: 10.1016/j.kint.2017.08.035.

PMID:
29291815
50.

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2018 Apr 1;33(4):653-660. doi: 10.1093/ndt/gfx197.

PMID:
29106648

Supplemental Content

Loading ...
Support Center